Patent ID: 8686053
Filing Date: 2014-04-01
Classification: A23D,A23L,A23V,A61K,A61P,C08B,C08L

Abstract:
1. A composition comprising an alginic acid and/or its salts with low molecular weight wherein the weight average molecular weight of said alginic acid ranges from about 800 to about 3,000 Daltons, and the molar ratio of guluronic acid units to mannuronic acid units in said alginic acid and/or its salts ranges from about 1 to about 18; and wherein the content of the alginic acid with low molecular weight and/or alginate salt ranges from about 60 wt % to about 90 wt %, or from about 30% to about 70% based on the total weight of the pharmaceutical composition; said composition may be administrated orally, rectally or parenterally for treating chronic renal failure, for improving hypertension, and for treating postprandial hyperglycemia caused by glycosidases.